Oscar Health Welcomes Two Healthcare Veterans to its Executive Leadership Team
September 06 2023 - 8:30AM
Business Wire
Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health
insurance company built around a full stack technology platform,
today announced the appointment of two seasoned healthcare
executives to round out its leadership bench and further propel its
vision to refactor healthcare. Kerry Sain has joined the company as
the Executive Vice President of +Oscar, effective August 14, 2023,
and Steven Kelmar will join as Executive Vice President and Chief
of Staff to the CEO, effective September 21, 2023.
In her role, Sain oversees the go-to-market strategy for the
+Oscar business and will work closely with Mario Schlosser,
President of Technology and Chief Technology Officer, to continue
externalizing the technology platform to power every aspect of the
healthcare system. Prior to joining Oscar, Sain served as the Chief
Commercial Growth Officer for Aetna, Inc., where she managed all
segments across its extensive commercial markets medical business.
Before Aetna, she held a variety of senior leadership positions at
13D Research & Strategy, SAP America, Inc., bswift, and Mercer.
Sain serves on the Executive Committee of the Foundation for the
University of the Virgin Islands and the Board of Directors of
digital-health company Mightier.
“Kerry is an absolute powerhouse,” said Mark Bertolini, CEO of
Oscar. “I had the pleasure of working alongside Kerry during my
time at Aetna, and have seen first-hand her ability to drive
aggressive growth strategies, build cutting-edge
software-as-a-service offerings, and effectively scale businesses.
I believe Kerry’s leadership, combined with Oscar’s member
engagement and technology superpowers, will set +Oscar up for
continued expansion.”
In his role, Kelmar will be responsible for driving corporate
strategy, guiding Oscar’s long-term growth roadmap, and evolving
executive management processes at the company. Kelmar previously
served as Senior Vice President of Strategy Implementation at CVS
Health Corporation and as Chief of Staff and Executive Vice
President, Head of Strategy, for the Office of The Chairman and CEO
at Aetna Inc. He has held a number of senior executive positions at
Novartis and Medtronic. Kelmar also served in President George H.
W. Bush’s administration as an Assistant Secretary at the U.S.
Department of Health and Human Services.
Bertolini continued, “Steve brings an incredible track-record of
accelerating business value creation and performance. He is a
long-time, trusted colleague who is joining at a pivotal moment in
Oscar’s history – with strategic targets, like achieving
profitability, within reach. I am confident Steve’s invaluable
leadership and deep alignment to our mission will help guide us
through our next phase of growth and catapult Oscar’s future
forward."
About Oscar Health
Oscar Health, Inc. (“Oscar”) is the first health insurance
company built around a full stack technology platform and a
relentless focus on serving its members. At Oscar, our mission is
to make a healthier life accessible and affordable for all.
Headquartered in New York City, Oscar has been challenging the
health care system's status quo since our founding in 2012. The
company’s member-first philosophy and innovative approach to care
has earned us the trust of nearly one million members, as of June
30, 2023. We offer Individual & Family, Small Group and
Medicare Advantage plans, and +Oscar, our full stack technology
platform, to others within the provider and payor space. Our vision
is to refactor health care to make good care cost less. Refactor is
a term used in software engineering that means to improve the
design, structure, and implementation of the software, while
preserving its functionality. At Oscar, we take this definition a
step further. We improve our members’ experience by building trust
through deep engagement, personalized guidance, and rapid
iteration.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements other than statements of historical fact
contained herein are forward-looking statements. These statements
include, but are not limited to, statements about our business and
financial prospects, and our management’s plans and objectives for
future operations, expectations and business strategy. In some
cases, you can identify forward-looking statements by terms such as
“may,” “will,” “should,” “expects,” “plans,” “anticipates,”
“could,” “intends,” “targets,” “projects,” “contemplates,”
“believes,” “estimates,” “predicts,” “potential,” or “continue” or
the negative of these terms or other similar expressions.
Accordingly, we caution you that any such forward-looking
statements are not guarantees of future performance and are subject
to risks, assumptions, and uncertainties that are difficult to
predict and generally beyond our control. Although management
believes that the expectations reflected in these forward-looking
statements are reasonable as of the date made, there are or will be
important factors that could cause our actual results to differ
materially from those indicated in these forward-looking
statements, including, but not limited to, the factors set forth
under the caption “Risk Factors” in our Quarterly Report on Form
10-Q for the quarterly period ended June 30, 2023, filed with the
Securities and Exchange Commission (“SEC”), and our other filings
with the SEC. You are cautioned not to place undue reliance on any
forward-looking statements made in this press release. Any
forward-looking statement speaks only as of the date as of which it
is made, and, except as otherwise required by law, we do not
undertake any obligation to publicly update or review any
forward-looking statement, whether as a result of new information,
future developments or otherwise. New factors emerge from time to
time, and it is not possible for us to predict which will
arise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230906189466/en/
INVESTOR RELATIONS: Chris Potochar 610-500-1260
ir@hioscar.com MEDIA RELATIONS: Kristen Prestano
516-317-1486 press@hioscar.com
Oscar Health (NYSE:OSCR)
Historical Stock Chart
From Apr 2024 to May 2024
Oscar Health (NYSE:OSCR)
Historical Stock Chart
From May 2023 to May 2024